Delisted from NYSE in Dec 2023
RAD - Rite Aid Corporation
NYSE
->
Healthcare
->
Pharmaceutical Retailers
Camp Hill,
United States
Type: Equity
RAD price evolution
RAD
| (in millions $) | 30 Jul 2023 | 31 Mar 2023 | 26 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $135.53 | $157.15 | $103.05 | $46.81 |
| Short term investments | ||||
| Net receivables | $1392.35 | $1149.96 | $1474 | $1564.39 |
| Inventory | $1950.41 | $1900.74 | $1981.34 | $2026.22 |
| Total current assets | $3649.46 | $3301.05 | $3678.22 | $3740.86 |
| Long term investments | ||||
| Property, plant & equipment | $3349.65 | $3404.98 | $3562.62 | $3630.46 |
| Goodwill & intangible assets | $601.32 | $758.05 | $886.89 | $894.98 |
| Total noncurrent assets | $4000.95 | $4226.31 | $4531.55 | $4626.26 |
| Total investments | ||||
| Total assets | $7650.42 | $7527.36 | $8209.77 | $8367.13 |
| Current liabilities | ||||
| Accounts payable | $1505.74 | $1494.61 | $1454.99 | $1511.67 |
| Deferred revenue | ||||
| Short long term debt | $494.77 | $508.74 | $569.6 | $577.53 |
| Total current liabilities | $2772.57 | $2727.88 | $2824.14 | $2818.77 |
| Long term debt | $5685.4 | $5310.78 | $3201.98 | $5733.14 |
| Total noncurrent liabilities | $5825.3 | $5441.26 | $5789.37 | $5884.76 |
| Total debt | $6180.17 | $5819.52 | $6199.42 | $6310.67 |
| Total liabilities | $8597.87 | $8169.14 | $8613.51 | $8703.52 |
| Shareholders' equity | ||||
| Retained earnings | -$6908.23 | -$6601.52 | -$6360.21 | -$6293.06 |
| Other shareholder equity | -$14.85 | -$14.85 | -$15.44 | -$15.44 |
| Total shareholder equity | -$947.45 | -$641.78 | -$403.73 | -$336.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $157.15 | $39.72 | $160.9 | $218.18 |
| Short term investments | ||||
| Net receivables | $1149.96 | $1343.5 | $1462.44 | $1286.79 |
| Inventory | $1900.74 | $1959.39 | $1864.89 | $1921.6 |
| Total current assets | $3301.05 | $3449.36 | $3595.17 | $3700.64 |
| Long term investments | $7.04 | |||
| Property, plant & equipment | $3404.98 | $3802.7 | $4144.58 | $4119.09 |
| Goodwill & intangible assets | $758.05 | $1170.33 | $1448.65 | $1467.63 |
| Total noncurrent assets | $4226.31 | $5079.65 | $5740.23 | $5751.73 |
| Total investments | ||||
| Total assets | $7527.36 | $8529 | $9335.4 | $9452.37 |
| Current liabilities | ||||
| Accounts payable | $1494.61 | $1571.26 | $1437.42 | $1484.08 |
| Deferred revenue | ||||
| Short long term debt | $508.74 | $581.2 | $523.16 | $499 |
| Total current liabilities | $2727.88 | $2933.09 | $2602.95 | $2766.46 |
| Long term debt | $5310.78 | $5344.91 | $5909.09 | $5806.94 |
| Total noncurrent liabilities | $5441.26 | $5496.88 | $6117.3 | $6011.38 |
| Total debt | $5819.52 | $5926.1 | $6432.25 | $6305.94 |
| Total liabilities | $8169.14 | $8429.97 | $8720.25 | $8777.84 |
| Shareholders' equity | ||||
| Retained earnings | -$6601.52 | -$5851.58 | -$5313.1 | -$5222.19 |
| Other shareholder equity | -$14.85 | -$15.44 | -$24.05 | -$48.9 |
| Total shareholder equity | -$641.78 | $99.03 | $615.15 | $674.53 |
| (in millions $) | 30 Jul 2023 | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6092.9 | $5901.07 | ||
| Cost of revenue | $4843.94 | $4746.57 | ||
| Gross Profit | $1248.96 | $1154.49 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1296.06 | $1193.55 | ||
| Total operating expenses | $1484.19 | $1462.6 | ||
| Operating income | -$235.23 | -$308.1 | ||
| Income from continuing operations | ||||
| EBIT | -$196.4 | -$266.79 | ||
| Income tax expense | -$21.42 | $11.97 | ||
| Interest expense | $66.33 | $52.53 | ||
| Net income | ||||
| Net income | -$241.31 | -$331.29 | ||
| Income (for common shares) | -$241.31 | -$331.29 | ||
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $24091.9 | $24043.24 | $21928.39 | |
| Cost of revenue | $19287.96 | $19338.92 | $17201.63 | |
| Gross Profit | $4803.94 | $4704.32 | $4726.76 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4902.09 | $4657.19 | $4587.34 | |
| Total operating expenses | $5416.09 | $4628.44 | $4634.4 | |
| Operating income | -$612.15 | $75.89 | $92.35 | |
| Income from continuing operations | ||||
| EBIT | -$532 | $90.32 | $165.09 | |
| Income tax expense | -$6.47 | -$20.16 | $387.61 | |
| Interest expense | $224.4 | $201.39 | $229.66 | |
| Net income | ||||
| Net income | -$749.94 | -$90.91 | -$452.17 | |
| Income (for common shares) | -$749.94 | -$90.91 | -$452.17 | |
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 |
|---|---|---|---|---|
| Net income | -$306.72 | -$241.31 | -$67.14 | -$331.29 |
| Operating activities | ||||
| Depreciation | $65.89 | $68.45 | $69.5 | $68.56 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.08 | $2.9 | $0.57 | $4.74 |
| Total cash flows from operations | -$372.54 | $266.41 | $132.61 | -$199.22 |
| Investing activities | ||||
| Capital expenditures | -$35.89 | -$42.72 | -$50.32 | -$49.07 |
| Investments | $8.16 | $36 | $19.93 | $56.15 |
| Total cash flows from investing | -$39.35 | -$14.18 | -$39.97 | $3.98 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | $398.99 | -$224.87 | -$37.06 | $234.97 |
| Total cash flows from financing | $390.26 | -$198.13 | -$36.4 | $186 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$21.62 | $54.1 | $56.25 | -$9.25 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$749.94 | -$538.48 | -$90.91 | -$452.17 |
| Operating activities | ||||
| Depreciation | $276.58 | $295.69 | $327.12 | $328.28 |
| Business acquisitions & disposals | -$86.23 | |||
| Stock-based compensation | $11.54 | $13.05 | $13 | $16.09 |
| Total cash flows from operations | -$52.44 | $379.27 | $22.99 | $487.02 |
| Investing activities | ||||
| Capital expenditures | -$215.28 | -$194.09 | -$195.14 | -$171.71 |
| Investments | $142.93 | $76.2 | $189.34 | $64.54 |
| Total cash flows from investing | -$104.76 | -$134.07 | -$15.03 | -$86.54 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.05 | |||
| Net borrowings | $263.06 | -$336.04 | -$8.62 | -$331.1 |
| Total cash flows from financing | $274.63 | -$366.38 | -$65.24 | -$326.65 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $117.43 | -$121.18 | -$57.28 | $73.83 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 56.43M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | -16.53 |
| Cash/Share | 2.40 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -12.73 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.32 |
| Quick ratio | 0.61 |